ROL › analyze
ROL · Analyze
Knowledge check
No prior Output/Stocks/**/ROL report and no live Knowledge/ note on ROL or Rollins
(python .mcp/kb.py find ROL returned only generic pitfalls, none ROL-specific). This is a
first-look analysis — nothing to cite or supersede. ROL is not dual-class, not an ADR, and
reports in USD from a US domicile, so the ADR/FX/dual-class pitfall family (pitfall-adr-*,
pitfall-yahoo-share-count-dual-class-fpi) does not apply — confirmed via get_stock_info
(country: United States) and marketCap ÷ price reconciling cleanly against sharesOutstanding.
Two pitfalls did apply directly and are flagged inline below:
[[pitfall-roicai-free-plan-caps-history-at-two-years]] (roic.ai only returned FY2024-25) and
[[pattern-incremental-margin-below-average-locks-in-decay]] (the Q2 incremental-margin arithmetic).
What ROL is
Rollins, Inc. — Orkin's parent — is the largest pure-play pest control company in the world: ~22,000 employees, a multi-brand portfolio (Orkin, HomeTeam Pest Defense, Fox Pest Control, Northwest Exterminating, Clark Pest Control, and dozens of tuck-in acquisitions) selling recurring residential and commercial pest control, termite, and mosquito/ancillary services across North America, and a smaller international footprint. Revenue splits roughly residential / commercial / termite-ancillary, with recurring contracted revenue as the backbone.
1. Fundamentals
| Metric | 2022 | 2023 | 2024 | 2025 | TTM (Q3'25-Q2'26) |
|---|---|---|---|---|---|
| Revenue | $2.70B | $3.07B | $3.39B | $3.76B | ~$3.92B |
| Gross margin | — | — | 52.7% | 52.75% | ~52.6% |
| Op margin | — | — | 19.39% | 19.30% | ~18.7% (Q2'26) |
| Net income | $368.6M | $435.0M | $466.4M | $526.7M | ~$556.8M (sum of last 4Q) |
| FCF | $435.3M | $495.9M | $580.1M | $650.0M | ~$619M |
| Diluted EPS | $0.75 | $0.89 | $0.96 | $1.09 | $1.07 (vendor ttm) |
| Shares (diluted) | 492.4M | 490.1M | 484.3M | 484.1M | 481.4M |
| Debt/Assets | 15.9% | — | 28.8% | 33.1% | — |
| Net debt/EBITDA | — | — | 0.40x | 0.60x | ~0.6x (mgmt states "1x leverage ratio," gross-debt basis) |
FCF and growth. Revenue 3yr CAGR 11.7%, net income 12.6%, FCF 14.3% — a genuine double-digit compounder on the 2022-25 window, funded mostly by organic pricing/volume plus 2-3%/yr of bolt-on M&A. FCF/share $1.34 (FY25, ~$1.29 TTM) — capex is trivial (~0.7-0.9% of revenue), so FCF tracks net income closely; this is an asset-light services roll-up, not a capital-intensive business.
2026 has genuinely decelerated, and the cash-flow data confirms it, not just management tone. Q2'26 revenue grew 7.9% (organic 5.7%) vs Q2'25's high-single-digit pace; Q2'26 net income of $143.9M is barely above Q2'25's $141.5M (+1.7% YoY) — a sharp slowdown from the 12-13% net-income CAGR of the prior three years. TTM FCF (~$619M, summing the last four quarterly statements) is roughly flat to slightly down versus FY2025's $650M — the first FCF deceleration since at least 2022. This is the "quality" side showing real cracks, not just a sentiment overreaction.
Capital allocation (FY2025). Of $650M FCF: capex -$28M, M&A -$310M (the largest single use — this is a serial-roll-up model), dividends -$328M, buybacks -$217M. Buybacks + dividends + M&A ($854M) exceeded FCF by ~$204M, funded by a net increase in debt (short+long-term debt rose from $813M to $1.04B). Leverage remains low in absolute terms (Debt/Assets 33%, net debt/EBITDA ~0.6x, EBITDA/interest ~30x) but the trend is toward more debt-funded capital return during an active M&A phase — worth watching, not yet a concern.
Shares outstanding fell from 492.4M (2022) to 481.2M (2025), a -0.6%/yr CAGR — a modest buyback tailwind. The November 2025 "secondary" that shows up in insider filings as three enormous trust/entity sales (R. Randall Rollins Voting Trust, Gary W. Rollins Voting Trust, and LOR Inc — the founding family's holding vehicles — selling ~59.3M shares combined at $56.93 on 2025-11-10) was confirmed on the Q2'26 earnings call as an underwritten secondary offering by the founding family, not new share issuance — the share count is unaffected and it reads as family-office diversification at a strong price, not distress selling. It is a legitimate overhang/attention item but not a fundamentals red flag on its own.
Dividend grower overlay. Quarterly dividend has risen every year for a decade (annualized total dividend/share: $0.22 in 2016 → $0.68 in 2025, a ~13% 9yr CAGR), with the latest raise (+10.9%, to $0.183/qtr) declared Nov 2025 and held flat through Aug 2026 — the next raise is due around Nov 2026 on the historical pattern. FCF payout ratio ≈ 50% (FY25 dividends $328M ÷ FCF $650M), comfortably covered even after the 2026 slowdown; EPS payout (roic.ai) runs ~62-64%, still sustainable. Verdict: dividend is safe; it is the growth/execution thesis that is under question, not the payout.
2. Moat & Competitive Advantage
ROIC and margin trend. ROIC (roic.ai return_on_inv_capital) is 24.2% (2025) vs 23.8%
(2024) — high and stable, the clearest quantitative moat signal. Gross margin has held a tight
52.6-52.8% band for years — no structural erosion at the annual level.
But the quarterly incremental-margin arithmetic is a genuine tension, not noise. Per [[pattern-incremental-margin-below-average-locks-in-decay]]: Q2'26 incremental operating margin was 6.5%, management's own guided full-year floor is "at least 10%," and the stated long-term target is "30%+." All three sit below the current ~19% average operating margin. While the incremental margin runs below the average, the average must keep falling — this is arithmetic, not a forecast. Management is explicit that H1'26 ran ~8% incremental and is counting on a Q4-weighted recovery to average >10% for the year. If the incremental margin does not recover above the ~19% average by 2027, the operating margin trend inflects down for the first time in this dataset — the single most important thing to check at the next print.
Revenue-stream / channel map. The quarter's damage was concentrated almost entirely in one channel: consumer-initiated digital demand (search, inbound calls) for the Orkin brand, where organic growth ran ~3.6% vs. a 7-8% target. Relationship-driven channels — door-to-door (Fox: high-teens organic; HomeTeam: double-digit), homebuilder partnerships, and commercial/termite (7-9% organic, in line with plan) — all held up. This is the multi-brand strategy doing exactly what it's supposed to do: a single-channel demand shock did not become a company-wide one. That said, Orkin is the largest brand by revenue, so its softness still dragged the consolidated number below plan for two straight quarters.
Adversarial stress-test. Pest control is a large, fragmented, technician-density business — a rival's easiest attack vector is not head-to-head service quality (retention stayed strong and management saw no evidence of share loss to named competitors), it's customer acquisition cost and channel ownership. Rollins does not control the digital channel it depends on for Orkin — Google/search intermediates it, and management could not rule out that LLM-mediated search (answer engines resolving "how do I get rid of ants" with DIY guidance, or routing to a lead-gen aggregator instead of a branded search result) is structurally eroding that funnel. This is a real, if unquantified, 3-5 year disruption vector for the digitally-dependent part of the portfolio specifically — door-to-door and homebuilder channels are largely immune to it, which is the moat-defense already underway (resource reallocation toward relationship-based brands, mentioned explicitly on the call).
Evergreen assessment. The category itself (pest control, termite protection) is genuinely non-discretionary once triggered and only modestly cyclical — this was never a "will people stop needing pest control" quarter, it was a "why did fewer people search for pest control in May-June 2026" quarter, and management's own multi-week root-cause effort could not settle on a single answer (weak consumer, weather/pest-pressure timing, or channel-mix/AI-search effects — "a confluence," in the CEO's words). The business is evergreen; the acquisition-channel mix inside it is not immune to disruption, and that's the distinction worth carrying forward.
3. Valuation
Graham's Intrinsic Value is not a usable model here — state that explicitly rather than
report a false number. √(22.5 × EPS × BVPS) = √(22.5 × 1.09 × 2.97) ≈ $8.46 against a
$35.94 price. This is not a signal that ROL is 4x overvalued; it's a formula failure. Rollins'
tangible book value per share is negative (-$1.21, roic.ai) because a decade of tuck-in
M&A has built $1.37B of goodwill — roughly equal to all of total equity ($1.37B). Graham's
formula assumes a real, tangible asset base standing behind the earnings; an asset-light,
brand-and-relationship-driven services roll-up has none, by design. Weight Graham at
essentially zero for this name (consistent with the framework: Graham is for "profitable
companies with real book value," which this isn't).
Own-historical-multiple-band check — the framework's better test
([[principle-down-a-lot-is-not-cheap]]: measure against a name's own band, not its 52-week
high). Reconstructing year-end P/E from fin.py EPS and quarterly closes: 2022 ~46x, 2023 ~47x,
2024 ~50x, 2025 ~55-57x (roic.ai pe_ratio 55.17 at FY25 close $60.02) — a persistent 45-57x
band for four straight years. Today's TTM P/E is 33.6x, forward P/E 27.6x. This is a
genuine break below the multiple ROL has sustained in any of the last four years, not merely
a discount to its 52-week high ($66.14) — unlike most of the names this agency has swept in
2026, ROL clears its own bar. (Caveat: forward P/E implies ~$1.30 forward EPS, a ~19% jump over
trailing $1.09 — plausible only if H2'26 stabilizes and FY27 estimates are blended in; flag per
[[pitfall-vendor-forward-eps-is-the-wrong-fiscal-year]] rather than take it at face value.)
FCF yield corroborates the same read. TTM FCF/share ≈ $1.29 ÷ $35.94 = 3.6% FCF yield, versus a 2024-25 norm of roughly 2.3-2.7% (implied by roic.ai's P/FCF of 37-43x). The stock is genuinely cheaper on cash generation than its recent history, not just on a compressed narrative multiple.
Bogle Expected Return. 2.0% dividend yield + a conservative forward earnings-growth assumption of 8-9% (below the historical 12-13%, deliberately discounted for the guidance cut) ± no assumed multiple change (base case) ≈ 10-11% expected return. Add back even a partial re-rating toward, say, 32-35x over 2-3 years (still well under the old 45-57x band) and the ER climbs into the mid-to-high teens. This is a reasonable, not extraordinary, return for a name whose near-term growth algorithm is genuinely in question.
Dividend Yield Theory — read with the standard caveat. Current yield 1.99% vs. 5yr average 1.15% is, on its face, a buy signal. But per [[pitfall-dyt-inverts-when-price-caused-the-yield]], decompose why: the dividend itself kept growing (+10.9% at the last raise) while the price collapsed ~46% from its Feb 2026 high — this yield expansion is entirely price-driven, not a generous new payout policy. Treat DYT here as corroborating the independent multiple-band and FCF-yield evidence above, not as standalone proof of cheapness.
DDM — explicitly not reliable at this discount-rate/growth-rate spread. With g≈9-10% (near-term dividend growth) and a reasonable discount rate for a low-beta (0.74) quality compounder of r≈8-8.5%, g and r are too close together for the Gordon model to produce a stable number — small assumption changes swing the output by 2-3x. Skipping a false-precision DDM output; the FCF-yield and multiple-band triangulation above is the load-bearing valuation work.
Fair value range: $38-50 (central ~$44). Built from (a) a normalized 30-38x forward P/E on ~$1.30-1.35 forward EPS (a deliberately-discounted band below the 45-57x historical range, to price in the live execution risk) and (b) a 3.0-3.5% normalized FCF yield on a modestly growing FCF/share — the two triangulate to the same range. This range should be read as execution-conditional: a clean Q3 print pulls it toward the top; a third consecutive miss would argue for compressing the multiple further toward 25x (~$32-40), i.e. closer to today's price with much less margin of safety.
4. Sentiment — why is it near its 52-week low right now
The move is large, recent, and traceable to two specific prints, not a slow bleed. Price went from a Feb 2026 high of $65.60 to a May 2026 low of $36.41 — a ~45% drawdown inside three months — then drifted sideways/down to today's $35.94, just above the 52-week low of $35.81.
- Q1 FY26 (reported ~Apr 23, 2026): revenue beat ($906.4M, +10.2% total/+6.6% organic), but adjusted operating margin fell ~100bps YoY (16.9%) — the first crack, and the point where the stock began its steep May decline.
- Q2 FY26 (reported ~Jul 22, 2026, call Jul 23): the second and larger shock. Adjusted EPS $0.32 missed the $0.34 consensus; organic growth of 5.7% missed plan; gross margin -100bps to 52.8%; EBITDA margin -120bps to 21.9%. Stock fell ~14% intraday/after-hours on the print. Management cut FY26 guidance: organic growth to "at least 6%" (from a 7-8% target) and incremental margins to "at least 10%" (well below the medium-term 30%+ algorithm). Argus Research downgraded ROL to Hold, calling this the second EPS miss in four quarters and flagging that a third miss at Q3 "would force a fundamental re-rating."
- Root cause, per management's own extensive (and unusually candid) post-mortem: a pronounced slowdown in consumer-initiated digital demand (search/inbound calls) specifically for Orkin, starting mid-quarter and easing only in the final weeks of June. Management explicitly could not isolate one cause — considered and partially dismissed weaker consumer confidence, regional weather/pest-pressure timing, competitive share loss (found none), and raised, without confirming, the possibility that LLM/AI-mediated search is diverting some demand away from traditional branded search. Customer retention and pricing power were both confirmed intact — this reads as a demand-generation/channel problem, not a competitive or customer-quality problem.
- A useful historical anchor the CEO offered unprompted: he compared this directly to Q2 2017, a similarly unexplained late-season demand air-pocket that fully reversed by Q3 that year. Management is betting on the same pattern; the market, after two misses, is no longer taking that bet on faith.
- Leadership transition. William Harkins became CFO as of this call (an internal promotion, previously EVP of commercial operations); the outgoing CFO (Kenneth Krause, per insider filings) is not mentioned further. Framed neutrally by management as continuity, one outlet flagged it among "things to watch" alongside the margin story — worth noting as a transition risk, not yet evidence of anything adverse.
- Insider activity, decomposed. The Nov 2025 founding-family secondary (~59.3M shares, $56.93, discussed under Valuation/Fundamentals) happened before the drawdown, at prices well above today's — a monetization event, not a warning sign timed to the decline. Separately, a steady cadence of smaller officer sales (CFO transition grants, General Counsel, other officers) through the Jan-Feb 2026 window at $56-63 looks like routine 10b5-1 profit-taking on vested awards, not a cluster of distress selling. No insider bought into the May-August 2026 decline — a mild yellow flag (no golden-flag insider buying to confirm the bottom), but also no fresh insider selling into the weakness, which would have been the more alarming signal.
- Analyst positioning: Yahoo consensus recommendation is "hold," mean price target $45.59 — ~27% above spot, i.e. the sell-side broadly agrees the stock is cheap on a target basis but is not willing to call it a buy until execution is proven.
Cyclical/sentiment vs. structural — the honest answer is "mostly cyclical, with one structural question still open." The demand air-pocket itself (weather/pest-pressure timing, consumer softness) has every hallmark of a cyclical, self-correcting wobble, and management's own 2017 precedent supports that read. The multi-brand model already proved resilient — the channels not exposed to digital search kept compounding through the exact same quarter. The one genuinely unresolved structural question is whether AI-mediated search is starting to erode Orkin's specific acquisition channel — management raised it, couldn't rule it out, and couldn't rule it in. That is exactly the kind of open question this framework should carry forward rather than resolve by assumption.
5. Synthesis — weighted verdict
ROL is a mature, dividend-growing, high-ROIC compounder currently mid-way through its first real growth/margin stumble in years, trading for the first time in this dataset below its own historical multiple band — a rarer and more meaningful signal than "down a lot," per the agency's own playbook. For a name of this type (mature dividend grower, moderate-not-explosive growth), Fundamentals + Valuation carry the most weight, with Moat and Sentiment supplying the two live risk factors that keep conviction from being higher.
Where the lenses agree: the balance sheet is fortress-grade (0.6x net debt/EBITDA, ~30x interest coverage), the dividend is safely covered on FCF (~50% payout) and still growing, ROIC is high and stable (24%), and the valuation — for once — is genuinely, not just optically, cheap against ROL's own history on both a P/E-band and an FCF-yield basis.
Where the tension sits, named explicitly: Fundamentals/Moat show the incremental-margin arithmetic (6.5% vs. a ~19% average) mechanically pulling the average operating margin down unless it recovers in H2 — management says it will, but has now missed its own targets twice. Sentiment shows a demand-side shock that is probably cyclical (multi-brand resilience, retention/pricing intact, a credible 2017 precedent) but carries one unresolved structural thread (AI-mediated search) that nobody, including management, can yet size. This is a case where "the dividend is safe and the thesis is still being tested" is the honest framing — not a value trap (no evidence of share loss, competitive erosion, or customer-base deterioration), but not yet a clean "great company, market is simply wrong" call either.
A portfolio-specific passage was removed from the public build.
Named risks: 1. A third consecutive EPS/organic-growth miss at Q3 FY26 — the single most falsifiable, dated risk. Watch specifically for incremental margin (needs to clear ~15% to be credible toward the "at least 10%" full-year floor) and Orkin-specific organic growth reconverging toward the 7-8% algorithm. 2. The AI-search/digital-channel disruption question is genuinely open, not resolved — size accordingly; this is a name to revisit rather than "buy and forget," specifically because management itself flagged the uncertainty. 3. CFO transition — newly installed, first call; watch for continuity in cost-discipline execution promised for H2.